BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34657593)

  • 1. Predictive P-score for treatment ranking in Bayesian network meta-analysis.
    Rosenberger KJ; Duan R; Chen Y; Lin L
    BMC Med Res Methodol; 2021 Oct; 21(1):213. PubMed ID: 34657593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ranking treatments in frequentist network meta-analysis works without resampling methods.
    Rücker G; Schwarzer G
    BMC Med Res Methodol; 2015 Jul; 15():58. PubMed ID: 26227148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theory and practice of Bayesian and frequentist frameworks for network meta-analysis.
    Sadeghirad B; Foroutan F; Zoratti MJ; Busse JW; Brignardello-Petersen R; Guyatt G; Thabane L
    BMJ Evid Based Med; 2023 Jun; 28(3):204-209. PubMed ID: 35760451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior Choices of Between-Study Heterogeneity in Contemporary Bayesian Network Meta-analyses: an Empirical Study.
    Rosenberger KJ; Xing A; Murad MH; Chu H; Lin L
    J Gen Intern Med; 2021 Apr; 36(4):1049-1057. PubMed ID: 33403620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence inconsistency degrees of freedom in Bayesian network meta-analysis.
    Lin L
    J Biopharm Stat; 2021 May; 31(3):317-330. PubMed ID: 33296239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches.
    Maiti R; Mishra A; Mishra BR; Jena M
    Psychopharmacology (Berl); 2021 Dec; 238(12):3347-3356. PubMed ID: 34751803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses.
    Béliveau A; Boyne DJ; Slater J; Brenner D; Arora P
    BMC Med Res Methodol; 2019 Oct; 19(1):196. PubMed ID: 31640567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Normalized Entropy to Measure Uncertainty of Rankings for Network Meta-analyses.
    Wu YC; Shih MC; Tu YK
    Med Decis Making; 2021 Aug; 41(6):706-713. PubMed ID: 33754893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis.
    Spineli LM
    BMC Med Res Methodol; 2019 Apr; 19(1):86. PubMed ID: 31018836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis and Indirect Comparisons: on Methods, Paradigms, and Biologic Treatments for Psoriasis.
    Puig L
    Actas Dermosifiliogr (Engl Ed); 2021 Mar; 112(3):203-215. PubMed ID: 33053367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting and assessing confidence in network meta-analysis results: an introduction for clinicians.
    Yang A; Pechlivanoglou P; Aoyama K
    J Anesth; 2022 Aug; 36(4):524-531. PubMed ID: 35641661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A design-by-treatment interaction model for network meta-analysis and meta-regression with integrated nested Laplace approximations.
    Günhan BK; Friede T; Held L
    Res Synth Methods; 2018 Jun; 9(2):179-194. PubMed ID: 29193801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian splines versus fractional polynomials in network meta-analysis.
    Heinecke A; Tallarita M; De Iorio M
    BMC Med Res Methodol; 2020 Oct; 20(1):261. PubMed ID: 33081698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of Bayesian and frequentist methods in random-effects network meta-analysis of binary data.
    Seide SE; Jensen K; Kieser M
    Res Synth Methods; 2020 May; 11(3):363-378. PubMed ID: 31955519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of various hip preservation treatments for non-traumatic osteonecrosis of the femoral head: A network meta-analysis of randomized controlled trials.
    Yu X; Zhang D; Chen X; Yang J; Shi L; Pang Q
    J Orthop Sci; 2018 Mar; 23(2):356-364. PubMed ID: 29291916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid methods including network meta-analysis to produce evidence in clinical decision support: a decision analysis.
    Eiring Ø; Brurberg KG; Nytrøen K; Nylenna M
    Syst Rev; 2018 Oct; 7(1):168. PubMed ID: 30342549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.
    Zhan ZJ; Yao WY; Zhang F; Qiu WZ; Liao K; Feng JH; Tan JY; Liu H; Yuan TZ; Zheng RH; Yuan YW
    Front Immunol; 2021; 12():719650. PubMed ID: 34413862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonproportional Hazards in Network Meta-Analysis: Efficient Strategies for Model Building and Analysis.
    Wiksten A; Hawkins N; Piepho HP; Gsteiger S
    Value Health; 2020 Jul; 23(7):918-927. PubMed ID: 32762994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian meta-analysis using SAS PROC BGLIMM.
    Rott KW; Lin L; Hodges JS; Siegel L; Shi A; Chen Y; Chu H
    Res Synth Methods; 2021 Nov; 12(6):692-700. PubMed ID: 34245227
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.